Since both myocardium and vasculature in the heart are excessively damaged following
myocardial infarction (MI), therapeutic strategies for treating MI hearts should concurrently …

A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

Reconstruction of bony defects is challenging when conventional grafting methods are used
because of their intrinsic limitations (biological cost and/or biological properties). Bone …

Myocardial infarction (MI) remains the most common cause of death worldwide. Many MI
survivors will suffer from recurrent heart failure (HF), which has been recognized as a …

Cell therapy has been a promising strategy for cardiac repair after injury or infarction;
however, low retention and engraftment of transplanted cells limit potential therapeutic …

Photoactivated materials have found widespread use in biological and medical applications
and are playing an increasingly important role in the nascent field of three-dimensional (3D) …

Abstract Three-dimensional (3D) bioprinting is a rapidly growing technology that has been
widely used in tissue engineering, disease studies, and drug screening. It provides the …

We have developed a novel method to deliver stem cells using 3D bioprinted cardiac
patches, free of biomaterials. Human induced pluripotent stem cell-derived cardiomyocytes …

There has been considerable progress in engineering cardiac scaffolds for the treatment of
myocardial infarction (MI). However, it is still challenging to replicate the structural specificity …

Biofabrication of cell supportive cardiac patches that can be directly implanted on
myocardial infarct is a potential solution for myocardial infarction repair. Ideally, cardiac …